Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
PJ view: Access to rare disease treatment should not be a rarity Policymakers and healthcare leaders must persevere with long overdue changes to improve access to treatments for rare diseases.…
Is a cure for epidermolysis bullosa on the horizon? New trials to repurpose drugs for the rare genetic skin condition epidermolysis bullosa are offering families a level of hope not seen before, raising the question of whether a cure may finally be in sight.…
Two-prescriber sign-off no longer required for isotretinoin The Medicines and Healthcare products Regulatory Agency said that scrapping the two-prescriber requirement will address delays in access to acne treatment for patients aged under 18 years old.…
Health news round-up: vaccinations off-site, child health and medicines shortages A weekly summary of important developments in health news that you may have missed.…
NICE approves twice-yearly infusion that ‘significantly outperforms’ usual treatments for severe lupus Guidance says obinutuzumab, taken with daily immunosuppressant tablet mycophenolate mofetil, could benefit around 12,000 people in England.…
Case-based learning: insect bites and stings How to identify and manage insect bites and stings, as well as prevention methods.…
Health news round-up: men’s health, AMR and nuclear fuel turned cancer drug A weekly summary of important developments in health news that you may have missed.…
People with eczema can bathe as often as they want, government-funded study finds Researchers found that the frequency in which participants washed had no correlation with increased skin dryness.…
Community pharmacy campaign launched to ease winter pressures on NHS NHS Wales’ ‘Help Us to Help You’ campaign promotes use of the common ailments service in community pharmacies via TV, radio and social media advertisements.…
